Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
125 hedge funds and large institutions have $666M invested in Five Prime Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 22 closing their positions.
432% more capital invested
Capital invested by funds: $125M → $666M (+$541M)
141% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 22
64% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 25
33% more funds holding
Funds holding: 94 → 125 (+31)
3% more call options, than puts
Call options by funds: $4.63M | Put options by funds: $4.51M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$53.7M |
| 2 |
RI
RTW Investments
New York
|
+$31.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$20.3M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$19.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$87.3M |
| 2 |
Renaissance Technologies
New York
|
-$4.53M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.76M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3.54M |
| 5 |
Barclays
London,
United Kingdom
|
-$2.45M |
FPRX Hedge Fund Activity: Q4 2020 in Review
125 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2020, worth a combined $666M — up 432% from $125M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new FPRX positions and 22 closed out — a net gain of 31 holders — while 41 added to existing stakes and 25 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $53.7M. The largest seller was BVF Inc, cutting an estimated $87.3M.
- 125 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2020, up from 94 in Q3 2020.
- Funds reported $666M of Five Prime Therapeutics, Inc. stock for Q4 2020, up 432% quarter-over-quarter.
- 53 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2020 and 22 closed out, a net change of +31 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q4 2020 was RA Capital Management, an estimated $53.7M added.
- The largest Five Prime Therapeutics, Inc. seller in Q4 2020 was BVF Inc, an estimated $87.3M sold.
Based on aggregated 13F filings for Q4 2020.